Integrated Nanotherapeutics

Integrated Nanotherapeutics Inc. is a biopharmaceutical company focused on the development of novel therapeutics and diagnostics in oncology and autoimmune diseases, including diabetes, where there remains an unmet medical need for treatments and diagnostic agents with improved efficacy. Our proprietary technology allows for the incorporation of any compound into lipid nanoparticle delivery systems, extending the advantages of the delivery system to all therapeutic and diagnostic agents. We envision that the application of our technology can make many existing drugs or formulations safer and more effective.